Skip to main content
. 2020 Sep 9;6(1):92–96. doi: 10.1001/jamacardio.2020.3723

Figure 2. Temporal Trends in PCSK9 Inhibitor Use and Spending From 2015 to 2018 Among Medicare Beneficiaries.

Figure 2.

A, Number of Medicare Part D beneficiaries receiving a PCSK9 inhibitor prescription from January 2015 to December 2018. B, Total Medicare spending on PCSK9 inhibitors from January 2015 to December 2018. C, Medicare spending per beneficiary for those receiving a PCSK9 inhibitor prescription from January 2015 to December 2018. Annual spending and savings were adjusted for inflation and reported in 2018 US dollars.